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Epilepsy and Ramadan 
The worldwide prevalence of epilepsy is over 65 million with greater prevalence in low income 
countries where access to diagnosis and management of epilepsy are also limited1. Prevalence in the 
UK is approximately 600,0002. Specific prevalence of epilepsy amongst the global Muslim population 
of 1.6 billion3, 3.4 million in the UK4, is not known though the disease burden is likely significant 
given the high prevalence in lower income countries where much of this population reside. Amongst 
Western Muslim populations factors such as inadequate or delayed access to medical services for 
lower socioeconomic groups; stigma surrounding epilepsy; consanguinity increasing genetic risk; 
presentation of symptomatic causes of epilepsy amongst immigrants not often encountered in 
Western populations; and a reliance on alternative or complementary therapies as well as 
conventional medicines may all contribute to challenges in the management of epilepsy5. 
Ramadan, the ninth month of the Islamic calendar, obliges adult Muslims to refrain from eating, 
drinking and conjugal relations from dawn until sunset for up to 30 days consecutively. Muslims are 
accustomed to a dramatic change of routine in this month involving an early pre-dawn meal 
(suhoor), a late post-sunset meal (iftar) and daily late-night prayers at the mosque or at home. The 
Islamic calendar is based on the lunar cycle meaning months cycle through the seasons, shifting by 
11 days annually in relation to the Gregorian calendar. The length of the day and hence the fast in 
countries further from the equator such as the UK can be up to 20 hours in Summer. In 2020 
Ramadan will begin in late April and end in late May; with fasts in the UK expected to be 
approximately 17-18 hours long. Rather than being perturbed by these challenges, many Muslims 
see Ramadan as a time of heightened spiritual fervour and community cohesion. Indeed fasting in 
Ramadan is more likely to be observed globally (93%)6 and by Western Muslims (80% in USA)7than 
other obligations such as the five daily prayers.  
Fasting in Ramadan presents a specific challenge for patients with epilepsy. Studies by Gomceli et al8 
and Abdou et al9  have demonstrated an increase in incidence of seizures amongst known epileptics 
during Ramadan. Advice and recommendations for fasting patients and their health care providers in 
a number of chronic health conditions10, particularly diabetes11, are now available aiding informed 
decision making. Advice specific to epilepsy is not readily available. This article aims to detail some of 
the relevant issues to facilitate health care professionals working with patients with epilepsy who 
are participating in Ramadhan; and also highlighting for Muslims with epilepsy the available options 
both in terms of religious law and management of epilepsy. 
Seizure risk during Ramadan 
Various factors can contribute to increased seizure risk in Ramadan. 
Changes to drug regimens are commonly required and may or may not be led by the physician. 
Driven by their zeal to participate in the religious customs, many Muslims with epilepsy may take 
risks particularly with altering drug regimens12. Most often this is due to the usual dosing regimen 
being incompatible with the length of fasts, particularly with twice daily dosing in Summer months 
when all oral consumption is condensed into a short period at night. Alteration to drug regimens in 
Ramadan is linked to a higher risk of increased seizure frequency than fasting with unaltered drug 
regimens8,9. Moreover, Muslim patients may hesitate to seek or dismiss the opinion of their health 
care professionals due to an assumption that religious needs and considerations won’t be 
understood or validated13. Physicians also may feel ill equipped to provide culturally sensitive advice 
and may inadvertently rely on preconceptions of the patient’s views rather than exploring the 
reasons for poor adherence to medication13.  
Participation in Ramadan can involve a significant change to routines and sleep patterns, fasting 
Muslims will often sleep and awaken later and will awaken through the night for a pre-dawn meal 
before the fast commences. Working hours are often adjusted to account for this in Muslim majority 
countries but this can present an added challenge for Muslims in non-Muslim majority countries. 
Disruption of sleep patterns and fatigue are frequently reported seizure triggers14 and sleep 
structure is known to be altered during periods of fasting with delayed sleep onset and impaired 
REM sleep15. This effect however has not been found in daytime sleepiness, cognitive function, sleep 
architecture, and circadian rhythm when lifestyle changes in Ramadan are controlled for, suggesting 
there is no inherent effect of fasting on these factors16. Adequate advice around obtaining enough 
sleep or adjusting sleeping patterns to incorporate daytime sleep should be provided. 
Dehydration and hypoglycaemia may be concerns in periods of hot weather or long fasts. Particular 
attention may need to be given to patients taking Topiramate due to compounded risk of 
nephrolithiasis. 
Identifying at risk patients 
In preparation for Ramadan, it is vital that patients and their doctors are able to form a plan for 
managing their seizure disorder and anti-epileptic drug (AED) use. We have suggested a stratification 
of patients into high or low risk depending on the tendency towards experiencing severe or 
prolonged seizures.  In general, safe fasting is usually possible for most people with epilepsy if they 
follow medical advice. Figure 1 below provides general guidance on risk stratifying patients and 
advice on fasting status, patients should be considered on a case by case basis. We envisage that 
people with epilepsy hoping to fast in Ramadan would consult with their treating physician or 
epilepsy specialist nurse at least 3 months prior to the commencement of Ramadan. 
 
Figure 1 - Risk stratification of patients with epilepsy and suitability of fasting in Ramadan 
Drugs 
Attributes of certain antiepileptic drugs (AEDs) such as half-life, side effects and method of clearance 
will affect their suitability for use in patients fasting during Ramadan. These considerations should be 
made in light of the time of year – fasts in Summer can be up to 20 hours long whilst in Winter may 





•1-2 Seizures whole adult life
•Maintained on single monotherapy 






•Maintained on combination AED because 
of poorly controlled seizures in past 
•Previous Status Epilepticus 
•Co-morbid conditions like BP, heart 
failure, malignancy, diabetes 
•Elderly 
Drug name Typical maintenance dose Half-life (hr) Method of clearance 
Lamotrigine 75-200mg BD 10-30 Hepatic 
Levetiracetam 1500mg BD <10 Renal 
Sodium valproate 60mg/kg/day, BD/TDS if IR, OD if MR  10-30 Hepatic 
Carbamazepine Up to 2.4g/day, TDS if IR, BD if MR 10-30 Hepatic 
Phenytoin 200-500mg, OD or 2 divided doses 10-30 Hepatic 
Lacosamide 100-200mg BD 10-30 Renal 
Perampanel* 4-12mg OD >30 Hepatic 
Topiramate 125-200mg in 2 divided doses 10-30 Hepatic + renal 
Zonisamide* 400-600mg OD >30 Renal 
Clobazam 20mg in 2 divided doses 10-30 Hepatic 
Clonazepam* Up to 4-8mg OD if stable dose 30-40 Hepatic 
Pregabalin 200-600mg in 2-3 divided doses <10 Renal 
 
Table 1 - AED attributes to consider in Ramadan prescribing.  
* = potentially suitable for once daily dosing.  
OD = once daily. BD = twice daily. IR = immediate release. MR = modified release 
Adapted from ‘Choosing antiepileptic drugs’ Doyle, Alick 201817 
Table 1 highlights attributes of AEDs which can aid in decision making around prescribing in 
Ramadan. Commonly prescribed AEDs such as Lamotrigine, Levetiracetam and Carbamazepine 
require twice daily dosing, and this can be difficult to implement in Summer months when the length 
of the fast is long and oral consumption is condensed into a short period overnight. It may be 
possible to take doses at the post-sunset and pre-dawn meals, thereby shortening the period in 
between doses compared to the usual routine but maintaining twice daily dosing. The minimum 
acceptable time period in between doses will vary depending on the drug, side effect profile and 
nature of seizure disorder but doses less than 6 hours apart may not be advisable. Drugs such as 
Perampanel, Zonisamide and Clonazepam which can be given once daily may be more suitable in 
these patients. It may be possible to prescribe AEDs conventionally given as a split dose twice daily, 
such as Lamotrigine or Levetiracetam, in one larger dose once daily. Again, this is dependent upon 
factors such as side effects and nature of seizures. Patients receiving renally excreted drugs such as 
Levetiracetam, Lacosamide, Zonisamide and Topiramate should be counselled about the added risks 
of dehydration, particularly of the increased risk of nephrolithiasis with Topiramate.  
Islamic rulings regarding Ramadhan and exemptions from fasting 
At its foundation Islamic law, the Shari’ah, aims to protect core values including an individual’s life, 
wellbeing and wealth. A degree of difficulty as a means of encouraging virtues such as patience is 
expected in Ramadan for those partaking in it, however religious law encourages the pre-emption of 
potential harm to health and wellbeing and provides exemptions and alternatives in place of the 
usual rituals. Islamic rulings make several exceptions to lift the obligation for fasting for those in 
whom it may entail hardship such as the elderly, those who are travelling, pregnant women and 
those with significant mental health illness. Those with pre-existing or current physical illness which 
may be significantly exacerbated by fasting are permitted to not fast. Such judgements may be 
based on previous experience of illness or the opinion of a qualified physician as well as a 
knowledgeable religious authority. If an individual is deemed high risk for fasting on medical grounds 
as per the criteria laid out in figure 1, this would confer a sufficient risk to their health in the opinion 
of religious law to consider them exempt from the obligation to fast and consider one of the 
alternatives below. It should be noted however that seizure disorders which present no threat to 
quality of life such as minor seizures with no loss of consciousness would not be considered a 
sufficient threat to life or wellbeing. 
Consideration should also be given to the potential impact of seizures or medication changes on 
driving status; breakthrough seizures or medication substitutions/reductions would necessitate not 
driving for 12 months and 6 months respectively for patients with group 1 licenses18. Subsequent 
impact on patient’s ability to continue employment or on public safety should be carefully 
considered when judging an individual’s suitability for fasting.  
Those exempted from fasting at a particular timepoint have several options dependent on their 
circumstances: 1) if the reason for exemption is temporary such as an acute monophasic illness, fasts 
can be made up at a later date once the person has recovered; 2) if the length of the fast is the 
causative issue and shorter fasts are feasible then fasts can be made up at another time of year; 3) if 
the barrier to fasting is expected to be insurmountable in the future then charitable donations of a 
specific amount to feed the poor, termed ‘fidyah’, can take the place of fasting.  
Although some routes of administration of medicines may be permitted during the fast by Islamic 
scholars, all agree that oral consumption of medicines is not allowed during the fast.  
It should be recognised that although unanimous opinion exists on certain issues, there is a breadth 
of opinion on a variety of issues and health-care providers may encounter Muslims with differing 
viewpoints on these issues. Furthermore, Muslim patients may not have an in-depth knowledge of 
some of the concepts discussed above. A layperson’s level of familiarity may be present, both of the 
medical and religious issues at hand. 
Decision making in the clinic 
Figure 2 proposes a flow chart that can be used as a decision-making aid bringing together the issues 
discussed thus far to demonstrate potential approaches to patients in the clinic. Factors considered 
are the inherent seizure risk of the patient; the length of the fast dependent on the time of year; and 
the patient’s dosing regimen. Other factors to consider include occupation, driving status, risk of 
dehydration and sleep patterns. 
The benefits of shared decision making in the epilepsy clinic are known19 and are especially 
applicable in this case. Exploring factors such as the importance of fasting to the individual; personal 
challenges around employment and sleep; concerns around medication changes and side effects; 
and the impact of any breakthrough seizures should all be considered. The potential for patients to 
dismiss medical advice particularly if it is seen to be rigid and uncompromising should not be 
ignored. Education regarding the risks of poor compliance with medication and increased seizure risk 
during Ramadan may be important in helping the patient make a balanced and informed decision on 
whether to fast. Low to moderate risk patients who are aware of the risks can be supported in their 
decision to fast with the necessary medical and practical precautions in place. Conversely high-risk 
patients who are determined to fast can be directed to seek further guidance from reliable religious 
sources and the exemption from fasting to protect life and wellbeing in Islamic law can be 
emphasised. 
 
Figure 2 - Decision making aid 
 
Conclusion 
Epilepsy is common worldwide and a large number of Muslims  with epilepsy will choose to fast 
during the month of Ramadan. Advice specific to epilepsy and fasting for health care professionals 
and patients is scarce. Seizure risk is increased during periods of fasting and usual medication 
regimens often require alteration during Ramadan. We have proposed stratifying patients into low 
and high risk based on nature of epilepsy and likelihood of seizure recurrence. Islamic law allows for 
exemption from fasting in cases where there is significant threat to an individual’s life and wellbeing 
and alternatives to the usual rituals are highlighted. Alteration of drug regimens when safe may be 
required, either switching to OD dosing or maintaining BD dosing with shortened gap between 
doses. Shared decision making with weight given to both the patient’s medical needs and religious 
preferences is encouraged. Further education amongst healthcare professionals as well as Muslim 
patients regarding both the risks of fasting in epilepsy and the alternative approaches offered by 
Islamic rulings is required.  
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